Anti-Ro/SSA antibodies in rheumatoid arthritis: Clinical and immunologic associations

Clinical and Experimental Rheumatology

Volumn 24, Issue 1, 2006, Pages 59-64

  Cavazzana, Ilaria ^c   Franceschini, Franco ^c   Quinzanini, Marzia ^c   Manera, Calogero ^a   Del Papa, Nicoletta ^b   Maglione, Wanda ^b   Comina, Denise ^b   Radice, Antonella ^a   Sinico, Renato A ^a   Cattaneo, Roberto ^c  

^a Spedali Civili ^*  (Italy)

^b ISTITUTO ORTOPEDICO GAETANO PINI   (Italy)

^c Spedali Civili   (Italy)

Author keywords

Anti Ro; ENA; Rheumatoid arthritis; Sj ren's syndrome; SSA

Indexed keywords

AUTOANTIBODY; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GOLD SALT; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; PENICILLAMINE; RO ANTIBODY; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; AMYLOIDOSIS; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CLINICAL FEATURE; COUNTER IMMUNOELECTROPHORESIS; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPISCLERITIS; FEMALE; FOLLOW UP; HUMAN; HYPERGAMMAGLOBULINEMIA; IMMUNE RESPONSE; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; REMISSION; RHEUMATOID ARTHRITIS; SALIVARY GLAND BIOPSY; SCLERITIS; TREATMENT OUTCOME; TREATMENT RESPONSE; XEROPHTHALMIA; XEROSTOMIA;

AMYLOIDOSIS; ANTIBODIES, ANTINUCLEAR; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; COUNTERIMMUNOELECTROPHORESIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE DISEASES; FEMALE; HUMANS; HYPERGAMMAGLOBULINEMIA; MALE; MIDDLE AGED; MITOCHONDRIA; ORAL ULCER; SCLERITIS; XEROPHTHALMIA;

EID: 33645077608     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. PROVOST TT, TALAL N, HARLEY JB, REICHLIN M, ALEXANDER EL: The relationship between anti-Ro (SS-A) antibody positive Sjögren's syndrome and anti-Ro(SS-A) antibody positive lupus erythematosus. Arch Dermatol 1988, 124: 63-71.
2. PROVOST TT, ARNETT FC, REICHLIN M: C2 deficiency, lupus erythematosus, and anticytoplasmic Ro(SS-A) antibodies. Arthritis Rheum 1983, 26: 1279-82.
3. TAPPAINER G, HINTNER H, SCHOLZ S, ALBERT E, LIHERT J, WOLFF K: Systemic lupus erythematosus in hereditary deficiency of the fourth component of complement. J Am Acad. Dermatol. 1982, 7: 66-79.
4. McCAULIFFE DP: Cutaneous diseases in adults associated with anti-Ro/SS-A autoantibody production. Lupus 1997, 6: 158-66.
5. BUYON JP, WINCHESTER RJ, SLADE SG et al.: Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Arthritis Rheum 1993, 36: 1263-73.
6. SKOPOULI FN, ANDONOPOULOS AP, MOUTSOPOULOS HM: Clinical implication of the presence of anti-Ro(SSA) antibodies in patients with rheumatoid arthritis. J Autoimmun 1988, 3: 381-8.
7. BERNSTEIN RM, BUNN CC, HUGHES GRV, FRANCOEUR AM, MATHEWS MP: Cellular protein and RNA antigens in autoimmume disease. Mol Biol Med 1984, 2: 105-20.
8. MOUTSOPOULOS HM, GIOTAKI H, MADDISON PJ, MAVRIDIS AC, DROSOS AA, SKOPOULI FN: Antibodies to cellular antigens in Greek patients with autoimmune rheumatic diseases: anti-Ro(SSA) antibody a possible marker of penicillamine-D intolerance. Ann Rheum Dis 1984, 43: 285-7.
9. MOUTSOPOULOS HM, SKOPOULI FN, SARRAS AK et al.: Anti-Ro(SSA) positive rheumatoid arthritis (RA): a clinicoserological group of patients with high incidence of D-penicillamine side effects. Ann Rheum Dis 1985, 44: 215-9.
10. TISHLER M, GOLBRUT B, SHOENFELD Y, YARON M: Anti-Ro(SSA) antibodies in patients with rheumatoid arthritis- a possible marker for gold induced side effects. J Rheumatol 1994, 21: 1040-2.
11. BOIRE G, MENARD HA, GENDRON M, LUSSIER A, MYHAL D: Rheumatoid arthritis: anti-Ro antibodies define a non-HLA-DR4 associated clinicoserological cluster. J Rheumatol 1993, 20: 1654-60.
12. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
13. MATTESON EL: Extraarticular features of rheumatoid arthritis and systemic involvement. In: HOCHBERG, SILMAN, SMOLEN, WEINBLATT, WIESMAN (Eds): Rheumatology 3rd Edition. Vol 1, Mosby 2003: 781-92.
14. SHARP JT, LIDSKY MD, COLLINS LS, MORELAND J: Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Arthritis Rheum 1971; 24: 706-29.
15. PINALS RS, MASI AT, LARSEN RA: Preliminary criteria for remission in rheumatoid arthritis. Arthritis Rheum 1981; 24: 1308-15.
16. 2glycoprotein I: a marker of antiphospholipid syndrome? Lupus 1995; 4: 122-30.
17. HARRIS EN: The Second International Anti-cardiolipin Standardization Workshop. The Kingston anti-phospholipid antibody study (KAPS) group. Ann J Clin Pathol 1990; 94: 476-84.
18. BERNSTEIN RM, BUNN CC, HUGHES GRV: Identification of antibodies to acidic antigens by counterimmunoelectrophoresis. Ann Rheum Dis 1982; 41: 554-5.
19. CLARK G, REICHLIN M, TOMASI TB: Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol 1969; 102: 117-22.
20. VENABLES PJW, SMITH PR, MAINI RN: Purification and characterization of the Sjögren's syndrome A and B antigens. Clin Exp Immunol 1983; 54: 731-8.
21. VITALI C, BOMBARDIERI S, JONSSON R et al.: Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61:554-8.
22. FRANCESCHINI F, CRETTI L, QUINZANINI M, RIZZINI FL, CATTANEO R: Deforming arthropathy of the hands in systemic lupus erythematosus is associated with antibodies to SSA/Ro and to SSB/La. Lupus 1994; 3:419-22.
23. SIMMONS-O'BRIEN E, SUEPHY C, WATSON R et al.: One hundred anti-Ro(SS-A) antibody positive patients: a 10-year follow-up. Medicine 1995; 74: 109-30.
24. PANUSH RS, EDWARDS NL, LONGLEY S, WEBSTER E: "Rhupus" syndrome. Arch Intern Med 1988; 148: 1633-36.
25. COHEN MG, WEBB J: Concurrence of rheumatoid arthritis and systemic lupus erythematosus: report of 11 cases. Ann Rheum Dis 1987; 46: 853-8.
26. REICHLIN M: Clinical manifestations associated with anti-Ro antibodies in adults. Semin Clin Immunol 1998; 1: 21-8.
27. TZOUFAS AG, MOUTSOPOULOS HM: Clinical significance of autoantibodies to Ro/SSA and La/SSB. In: Manual of Biological Markers of Disease, Kluwer Academic Publishers, 1996: C4.1, 1-14.
28. LOUIS M, RAUCH J, ARMSTRONG M, FITZCHARLES MA: Induction of autoantibodies during prolonged treatment with infliximab. J Rheumatol 2003; 30: 2557-62.
29. BOBBIO-PALLAVICINI F, ALPINI C, CAPORALI R, AVALLE S, BUGATTI S, MONTECUCCO M: Autoantibody profile in rheumatoid arthritis during long term infliximab treatment. Arthritis Res Ther 2004; 6: R264-72.
30. CUSH JJ: Unusual toxicities with TNF inhibition: heart failure and drug-induced lupus. Clin Exp Rheumatol 2004; 22 (Suppl. 35): S141-147.
31. ALLANORE Y, SELLAM J, BATTEUX F, JOB DESLANDRE C, WEILL B, KAHAN A: Induction of autoantibodies in refractory rheumatoid arthritis treated by infliximab. Clin Exp Rheumatol 2004; 22: 756-8.
32. DE RYCKE L, KRNITHOG E, VAN DAMME N et al.: Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondyloarthropathy. Arthritis Rheum 2003; 48: 1015-23.